MX2019005199A - Métodos para evaluar el riesgo usando and libre de células total y específico. - Google Patents

Métodos para evaluar el riesgo usando and libre de células total y específico.

Info

Publication number
MX2019005199A
MX2019005199A MX2019005199A MX2019005199A MX2019005199A MX 2019005199 A MX2019005199 A MX 2019005199A MX 2019005199 A MX2019005199 A MX 2019005199A MX 2019005199 A MX2019005199 A MX 2019005199A MX 2019005199 A MX2019005199 A MX 2019005199A
Authority
MX
Mexico
Prior art keywords
methods
specific cell
total
free dna
assessing risk
Prior art date
Application number
MX2019005199A
Other languages
English (en)
Inventor
Mitchell Michael
Tomita Mitchell Aoy
Stamm Karl
Original Assignee
Medical College Wisconsin Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2017/030293 external-priority patent/WO2017190106A1/en
Application filed by Medical College Wisconsin Inc filed Critical Medical College Wisconsin Inc
Publication of MX2019005199A publication Critical patent/MX2019005199A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2560/00—Nucleic acid detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Esta invención se relaciona con métodos y composiciones para evaluar riesgos mediante la medición de ácidos nucleicos (tales como ADN) totales y específicos libres de células en un sujeto; los métodos y las composiciones aquí provistos pueden ser utilizados para determinar el riesgo de una condición, tal como el rechazo al trasplante.
MX2019005199A 2016-11-02 2017-11-02 Métodos para evaluar el riesgo usando and libre de células total y específico. MX2019005199A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662416689P 2016-11-02 2016-11-02
PCT/US2017/030293 WO2017190106A1 (en) 2016-04-29 2017-04-29 Multiplexed optimized mismatch amplification (moma)-target number
PCT/US2017/059808 WO2018085603A1 (en) 2016-11-02 2017-11-02 Methods for assessing risk using total and specific cell-free dna

Publications (1)

Publication Number Publication Date
MX2019005199A true MX2019005199A (es) 2019-10-14

Family

ID=62076613

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005199A MX2019005199A (es) 2016-11-02 2017-11-02 Métodos para evaluar el riesgo usando and libre de células total y específico.

Country Status (10)

Country Link
US (1) US20190367972A1 (es)
EP (1) EP3535413A1 (es)
JP (1) JP2019534016A (es)
CN (1) CN110114477A (es)
AU (1) AU2017355464A1 (es)
CA (1) CA3042696A1 (es)
EA (1) EA201991105A1 (es)
IL (1) IL266382A (es)
MX (1) MX2019005199A (es)
WO (1) WO2018085603A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2572003A4 (en) 2010-05-18 2016-01-13 Natera Inc METHOD FOR NONINVASIVE PRANATAL PLOIDIE ASSIGNMENT
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
CN106460070B (zh) 2014-04-21 2021-10-08 纳特拉公司 检测染色体片段中的突变和倍性
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
JP2019534017A (ja) * 2016-11-02 2019-11-28 ザ メディカル カレッジ オブ ウィスコンシン，インコーポレイテッドＴｈｅ Ｍｅｄｉｃａｌ Ｃｏｌｌｅｇｅ ｏｆ Ｗｉｓｃｏｎｓｉｎ， Ｉｎｃ． ミスマッチ増幅を使用するリスクを評価するための方法および統計方法
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
WO2018237075A1 (en) * 2017-06-20 2018-12-27 The Medical College Of Wisconsin, Inc. ASSESSING THE RISK OF GRAFT COMPLICATION WITH TOTAL ACELLULAR DNA
WO2019217918A1 (en) * 2018-05-10 2019-11-14 The Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (moma)-cancer risk assessment with non-cancer associated targets
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US11931674B2 (en) * 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
WO2021207244A1 (en) * 2020-04-06 2021-10-14 The Medical College Of Wisconsin, Inc. Methods for assessing the severity of, and for inhibiting, pro-inflammatory responses with total cell-free dna
JP2024507536A (ja) * 2021-02-25 2024-02-20 ナテラ， インコーポレイテッド 複数の臓器の移植レシピエントにおけるドナー由来無細胞ｄｎａの検出方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2496720T3 (pl) * 2009-11-06 2021-01-11 The Board Of Trustees Of The Leland Stanford Junior University Nieinwazyjna diagnoza odrzucenia przeszczepu u pacjentów z przeszczepem narządu
EP2551356B1 (en) * 2010-03-24 2017-06-14 Toppan Printing Co., Ltd. Method for detecting target base sequence using competitive primer
US10131947B2 (en) * 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
AU2013249012B2 (en) * 2012-04-19 2019-03-28 The Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free DNA
US20140242582A1 (en) 2013-02-28 2014-08-28 Ariosa Diagnostics, Inc. Detection of genetic abnormalities using ligation-based detection and digital pcr
LT3004388T (lt) * 2013-05-29 2019-01-25 Chronix Biomedical Donoro ne ląstelinės dnr aptikimas ir jos kiekio nustatymas organo transplantanto recipientų apytakoje
TR201907106T4 (tr) * 2014-03-14 2019-06-21 Caredx Inc Bir transplant alıcısında immünosüpresif terapileri izleme yöntemleri.
CN107223159A (zh) * 2014-05-09 2017-09-29 科戴克斯生命股份公司 源自特定细胞类型的dna的检测及相关方法
US10435750B2 (en) * 2014-07-03 2019-10-08 Multiplicom N.V. Methods for non-invasive detection of transplant health or rejection
ES2708030T3 (es) * 2014-10-20 2019-04-08 Inst Nat Sante Rech Med Métodos para explorar a un individuo en busca de un cáncer
WO2016123698A1 (en) * 2015-02-06 2016-08-11 Uti Limited Partnership Diagnostic assay for post-transplant assessment of potential rejection of donor organs
AU2016255573A1 (en) * 2015-04-30 2017-12-21 The Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing cell-free DNA
AU2017258800A1 (en) * 2016-04-29 2018-12-20 The Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing fetal well being

Also Published As

Publication number Publication date
AU2017355464A1 (en) 2019-05-30
CN110114477A (zh) 2019-08-09
EP3535413A1 (en) 2019-09-11
CA3042696A1 (en) 2018-05-11
IL266382A (en) 2019-06-30
WO2018085603A1 (en) 2018-05-11
JP2019534016A (ja) 2019-11-28
EA201991105A1 (ru) 2020-01-27
US20190367972A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
MX2019005199A (es) Métodos para evaluar el riesgo usando and libre de células total y específico.
MX2017013878A (es) Amplificación de discordancias optimizadas multiplicadas (moma) - reacción en cadena de polimerasa (pcr) en tiempo real, para evaluar el ácido desoxirribonucleico (adn) libre de celula.
MX2018013224A (es) Número de objetivo por amplificación de discordancias optimizada multiplicada (moma).
SG10202108763UA (en) Methods and compositions for nucleic acid analysis
EP4303314A3 (en) Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
IL287607A (en) Preparations, kits and methods for inducing acquired cellular resistance using inducible stress proteins
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение
MX2018013261A (es) Reacción de cadena de polimerasas para amplificación de discordancias optimizada multiplicada (moma)-en tiempo real para la valoración del bienestar fetal.
MX2016006165A (es) Composiciones y metodos para valorar la funcion intestinal.
MX2020001809A (es) Metodos para determinar acido desoxirribonucleico circulante de donante sin genotipo de donante.
MX2022013471A (es) Metodo y composiciones de deteccion y cuantificacion de acido nucleico.
MX2020012893A (es) Formulaciones de proteinas.
MX2016013308A (es) Uso de oxotetrahidroquinolinilsulfonamidas sustituidas o sus sales para aumentar la tolerancia al estres en plantas.
GB201716963D0 (en) Compositions and methods for use in stabilising nucleic acid amplification assays
MX2018013223A (es) Reacción de cadena de polimerasas para amplificación de discordancias optimizada multiplicada (moma)-en tiempo real para la valoración de cáncer.
EP3098311A4 (en) Method for measuring modified nucleobase using guide probe, and kit therefor
EA201691702A1 (ru) Химерные белки мти
MX2017014247A (es) Metodos para valorar la pureza de una preparacion de celulas germinales mesenquimales.
MX2017011198A (es) Biomarcadores para preeclampsia.
HUE052845T2 (hu) Eljárások enzimalapú elektrokémiai érzékelõk tesztelésére
MX2016017136A (es) Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
WO2015175534A3 (en) Compositions and methods employing stem cell-derived cardiomyocytes
PH12015502538A1 (en) Plants having one or more enhanced yield-related traits and a method for making the same
DK3215822T3 (da) Fremgangsmåder til anvendelse i fibermålinger, såsom multi-modus fibergeometrimålinger